226 related articles for article (PubMed ID: 11839765)
1. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Zhong WB; Wang CY; Chang TC; Lee WS
Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
[TBL] [Abstract][Full Text] [Related]
3. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
5. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
Fernández-Hernando C; Suárez Y; Lasunción MA
Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
[TBL] [Abstract][Full Text] [Related]
7. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
8. Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.
Vitale M; Di Matola T; Rossi G; Laezza C; Fenzi G; Bifulco M
Endocrinology; 1999 Feb; 140(2):698-704. PubMed ID: 9927296
[TBL] [Abstract][Full Text] [Related]
9. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
Stark WW; Blaskovich MA; Johnson BA; Qian Y; Vasudevan A; Pitt B; Hamilton AD; Sebti SM; Davies P
Am J Physiol; 1998 Jul; 275(1):L55-63. PubMed ID: 9688935
[TBL] [Abstract][Full Text] [Related]
11. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
12. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
14. Role for protein geranylgeranylation in adult T-cell leukemia cell survival.
Nonaka M; Uota S; Saitoh Y; Takahashi M; Sugimoto H; Amet T; Arai A; Miura O; Yamamoto N; Yamaoka S
Exp Cell Res; 2009 Jan; 315(2):141-50. PubMed ID: 18992741
[TBL] [Abstract][Full Text] [Related]
15. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
18. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
Hasmim M; Bieler G; Rüegg C
J Thromb Haemost; 2007 Jan; 5(1):166-73. PubMed ID: 17059425
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
20. Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s).
Liu L; Moesner P; Kovach NL; Bailey R; Hamilton AD; Sebti SM; Harlan JM
J Biol Chem; 1999 Nov; 274(47):33334-40. PubMed ID: 10559211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
